SIGA SIGA Technologies Inc. - Common Stock
NASDAQ · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$3,38
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,8352-Wochen-Tief
$9,1752-Wochen-Hoch
Marktkapitalisierung (MRQ)
$243M
P/E (TTM)
-84.5
EPS (TTM)
$-0.04
Umsatz (TTM)
$54M
Ihre Abzeichen
52W-Spanne
$3–$9
Analystenbewertung
·
Kursziel
·
P/E
-84.5
ROE
-1.5%
Nettogewinnmarge
-5.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
SIGA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.38
Marktkapitalisierung (MRQ)
$243M
P/E (TTM)
-84.5
EPS (TTM)
$-0.04
Umsatz (TTM)
$54M
Dividendenrendite
17.8%
ROE (TTM)
-1.5%
52W-Spanne
$3–$9
SIGA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$95M2018-12-31 → 2025-12-31
EPS$0.322016-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2019-12-31
Nettogewinnmarge-5.2%2020-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | SIGA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -84.55-Jahres-Durchschnitt ≈11.3 | ≈11.3 | · | · | |
| P/S (TTM) | 4.55-Jahres-Durchschnitt ≈3.9 | ≈3.9 | · | · | |
| K/B (MRQ) | 1.55-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 1.6 | Fairer Wert | |
| Price / Cash Flow (Kurs / Cashflow) | 5.65-Jahres-Durchschnitt ≈16.8 | ≈16.8 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.25-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | SIGA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -20.8%5-Jahres-Durchschnitt ≈48.1% | ≈48.1% | -310.2% | Spitzenklasse | |
| EBITDA-Marge (TTM) | -19.7%5-Jahres-Durchschnitt ≈48.5% | ≈48.5% | 2.5% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -10.3%5-Jahres-Durchschnitt ≈51.3% | ≈51.3% | 36.2% | Im Einklang | |
| Nettogewinnmarge (TTM) | -5.2%5-Jahres-Durchschnitt ≈39.7% | ≈39.7% | 30.4% | Im Einklang | |
| ROA (TTM) | -1.4%5-Jahres-Durchschnitt ≈23.7% | ≈23.7% | -13.1% | Spitzenklasse | |
| ROE (TTM) | -1.5%5-Jahres-Durchschnitt ≈30.8% | ≈30.8% | -33.5% | Spitzenklasse | |
| ROIC | 9.1%5-Jahres-Durchschnitt ≈25.3% | ≈25.3% | -14.4% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | SIGA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 21.75-Jahres-Durchschnitt ≈8.2 | ≈8.2 | 5.0 | Starke Liquidität | |
| Quick Ratio | 8.85-Jahres-Durchschnitt ≈6.4 | ≈6.4 | 1.5 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | SIGA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -31.8%5-Jahres-Durchschnitt ≈-3.3% | ≈-3.3% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -5.1%5-Jahres-Durchschnitt ≈-0.02% | ≈-0.02% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -5.4% | · | · | · | |
| EPS YoY (EPS VjV) | -61.0%5-Jahres-Durchschnitt ≈2.1% | ≈2.1% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -60.7%5-Jahres-Durchschnitt ≈-0.17% | ≈-0.17% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -11.4%5-Jahres-Durchschnitt ≈-1.5% | ≈-1.5% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -14.7% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -11.8%5-Jahres-Durchschnitt ≈-3.5% | ≈-3.5% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -16.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | SIGA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.4 | Im Einklang | |
| Inventory Turnover (Lagerumschlag) | 0.65-Jahres-Durchschnitt ≈0.5 | ≈0.5 | 0.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 7.75-Jahres-Durchschnitt ≈4.7 | ≈4.7 | 6.1 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$1.9M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite17.8%
Ausschüttungsquote185.2%
Annualisierte Auszahlung≈$0.60
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Apr 7, 2026 | $0,60 | USD | ≈13.2% |
| Apr 29, 2025 | $0,60 | USD | ≈10.4% |
| Mär 25, 2024 | $0,60 | USD | ≈7.2% |
| Mai 15, 2023 | $0,45 | USD | ≈7.8% |
| Mai 16, 2022 | $0,45 | USD | ≈6.1% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $0.17 | — | — |
| 31. März 2026 | $-0.05 | — | — | |
| 31. Dezember 2025 | $-0.08 | — | — | |
| 30. September 2025 | $-0.09 | — | — | |
| 30. Juni 2025 | $0.49 | — | — | |
| 31. März 2025 | $-0.01 | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $95M | $139M | $140M | $111M | $134M | $125M | $27M | $477M | |
| Cost of Revenue | $30M | $31M | $18M | $10M | $17M | $15M | $2M | $95M | |
| R&D Expense | $20M | $12M | $16M | $23M | $10M | $11M | $13M | $13M | |
| SG&A Expense | $21M | $25M | $22M | $35M | $18M | $15M | $13M | $13M | |
| Operating Expenses | $71M | $69M | $56M | $68M | $45M | $40M | $29M | $122M | |
| Operating Income | $24M | $70M | $84M | $43M | $89M | $85M | $-2M | $355M | |
| Interest Expense | · | · | · | $0 | $0 | $3M | $16M | $15M | |
| Other Non-op | $7M | $6M | $4M | $1M | $101.2K | $532.1K | $3M | $79M | |
| Pretax Income | $30M | $76M | $88M | $44M | $89M | $74M | $-10M | $412M | |
| Income Tax | $7M | $17M | $20M | $10M | $20M | $17M | $-3M | $-10M | |
| Net Income | $23M | $59M | $68M | $34M | $69M | $56M | $-7M | $422M | |
| EPS (Basic) | $0.33 | $0.83 | $0.95 | $0.46 | $0.92 | $0.71 | $-0.09 | $5.28 | |
| EPS (Diluted) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 | $0.71 | $-0.15 | $5.18 | |
| Shares (Basic) | 71,528,043 | 71,253,172 | 71,362,209 | 72,929,550 | 75,322,194 | 79,259,000 | 81,031,254 | 79,923,295 | |
| Shares (Diluted) | 71,867,627 | 71,905,712 | 71,679,270 | 73,546,501 | 76,402,716 | 79,437,306 | 82,175,023 | 82,708,472 | |
| EBITDA | $24M | $71M | $84M | $43M | $90M | $85M | $-2M | $355M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $155M | $155M | $150M | $99M | $103M | $118M | $65M | $101M | |
| Receivables | $3M | $21M | $21M | $45M | $84M | $3M | $4M | $2M | |
| Inventory | $49M | $50M | $64M | $39M | $20M | $20M | $10M | $3M | |
| Prepaid Expense | $6M | $5M | $3M | $2M | $2M | $2M | $5M | $4M | |
| Current Assets | $213M | $231M | $239M | $186M | $209M | $144M | $180M | $121M | |
| PP&E (Net) | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $171.3K | |
| PP&E (Gross) | $8M | $7M | $7M | $7M | $7M | $6M | $6M | $3M | |
| Accum. Depreciation | $7M | $6M | $6M | $5M | $5M | $4M | $4M | $3M | |
| Goodwill | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | |
| Other Non-current Assets | $192.9K | $240.7K | $2M | $252.5K | $286.6K | $676.9K | $856.8K | $1M | |
| Total Assets | $219M | $244M | $254M | $195M | $215M | $150M | $199M | $203M | |
| Accounts Payable | $824.5K | $1M | $1M | $3M | $2M | $1M | $3M | $2M | |
| Accrued Liabilities | $7M | $6M | $10M | $6M | $9M | $8M | $9M | $10M | |
| Short-term Debt | · | · | · | · | · | $0 | $80M | $0 | |
| Current Liabilities | $18M | $25M | $54M | $22M | $30M | $10M | $92M | $11M | |
| Capital Leases | $200.0K | $800.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | $3M | $3M | · | · | · | · | · | · | |
| Total Liabilities | $21M | $29M | $57M | $25M | $40M | $20M | $101M | $101M | |
| Long-term Debt | · | · | · | · | · | · | · | $76M | |
| Total Debt | · | · | · | · | · | $0 | $80M | · | |
| Common Stock | $7.2K | $7.1K | $7.1K | $7.3K | $7.4K | $7.7K | $8.1K | $8.1K | |
| Retained Earnings | $-43M | $-23M | $-39M | $-64M | $-52M | $-95M | $-123M | $-116M | |
| Stockholders' Equity | $199M | $216M | $197M | $170M | $174M | $130M | $98M | $103M | |
| Liabilities + Equity | $219M | $244M | $254M | $195M | $215M | $150M | $199M | $203M | |
| Shares Outstanding | 71,611,302 | 71,404,669 | 71,091,616 | 72,675,190 | 73,543,602 | 77,195,704 | 81,269,868 | 80,763,350 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $562.6K | $538.4K | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | $69.6K | |
| Stock-based Comp | $4M | $4M | $2M | $2M | $1M | $1M | $2M | $2M | |
| Deferred Tax | $6M | $193.4K | $-5M | $-4M | $121.4K | $12M | $-2M | $-9M | |
| Other Non-cash | $10M | $-15M | $29M | $9M | $-60M | $2M | $-11M | $-346M | |
| Operating Cash Flow | $43M | $49M | $95M | $42M | $11M | $72M | $-18M | $69M | |
| CapEx | · | · | · | · | · | · | $29.1K | $102.3K | |
| Investing Cash Flow | $-355.0K | $-42.5K | $-21.7K | $0 | $-50.6K | $-15.5K | $-29.1K | $78M | |
| Net Debt Issued | · | · | · | $0 | $0 | $-86M | · | · | |
| Stock Repurchased | $0 | $0 | $11M | $13M | $26M | $29M | $0 | $0 | |
| Net Stock Activity | $0 | $0 | $-11M | $-13M | $-26M | $-29M | $0 | $0 | |
| Dividends Paid | $43M | $43M | $32M | $33M | $0 | $0 | · | · | |
| Financing Cash Flow | $-44M | $-43M | $-43M | $-46M | $-26M | $-115M | $-1M | $-4M | |
| Net Change in Cash | · | · | · | · | · | · | · | $143M | |
| Taxes Paid | $8M | $30M | $4M | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | $-18M | $69M | |
| Levered FCF | · | · | · | · | · | · | $-29M | $53M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 25.1% | 50.4% | 59.8% | 38.6% | 66.6% | 67.6% | · | · | |
| Net Margin | 24.6% | 42.7% | 48.6% | 30.6% | 52.0% | 45.1% | · | · | |
| Pretax Margin | 32.1% | 54.8% | 62.7% | 39.8% | 66.8% | 58.8% | · | · | |
| EBITDA Margin | 25.7% | 50.8% | 60.2% | 39.0% | 67.0% | 68.0% | · | · | |
| ROA | 10.0% | 23.8% | 30.3% | 16.6% | 38.1% | 32.3% | -3.6% | 242.3% | |
| ROE | 11.4% | 30.7% | 42.4% | 19.8% | 49.5% | 46.4% | -7.2% | 542.9% | |
| ROIC | 9.1% | 25.2% | 32.9% | 19.3% | 39.7% | 49.9% | -0.93% | 353.6% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | 9.1 | 4.4 | 8.6 | 6.8 | 13.7 | 2.0 | 10.7 | |
| Quick Ratio | 8.8 | 7.0 | 3.2 | 6.7 | 6.1 | 11.6 | 0.8 | 9.1 | |
| Debt / Equity | · | · | · | · | · | 0.0 | 0.8 | · | |
| Interest Coverage | · | · | · | · | · | 28.0 | -0.1 | 22.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.6 | 0.6 | 0.5 | 0.7 | 0.7 | · | · | |
| Inventory Turnover | 0.6 | 0.6 | 0.3 | 0.4 | 0.8 | 1.0 | 0.3 | 32.3 | |
| Receivables Turnover | 7.7 | 6.6 | 4.2 | 1.7 | 3.1 | 33.3 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.78 | $3.02 | $2.77 | $2.34 | $2.37 | $1.68 | $1.20 | $1.27 | |
| Revenue / Share | $1.32 | $1.93 | $1.95 | $1.51 | $1.75 | $1.57 | · | · | |
| Cash Flow / Share | $0.60 | $0.68 | $1.32 | $0.57 | $0.15 | $0.90 | $-0.22 | $0.83 | |
| Cash / Share | $2.16 | $2.18 | $2.11 | $1.36 | $1.40 | $1.53 | $0.80 | $1.25 | |
| Dividend Paid / Share | $0.60 | $0.60 | $0.45 | $0.45 | · | · | · | · | |
| EPS (TTM) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 | $0.71 | $-0.15 | $5.18 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -31.8% | -0.86% | 26.3% | -17.1% | 7.0% | · | · | · | |
| Revenue CAGR 3Y | -5.1% | 1.2% | 3.8% | · | · | · | · | · | |
| Revenue CAGR 5Y | -5.4% | · | · | · | · | · | · | · | |
| EPS YoY | -61.0% | -13.7% | 106.5% | -49.5% | 28.2% | · | · | · | |
| EPS CAGR 3Y | -11.4% | -3.4% | 10.2% | · | · | · | · | · | |
| EPS CAGR 5Y | -14.7% | · | · | · | · | · | · | · | |
| Net Income YoY | -60.7% | -13.0% | 100.8% | -51.2% | 23.3% | · | · | · | |
| Net Income CAGR 3Y | -11.8% | -5.2% | 6.5% | · | · | · | · | · | |
| Net Income CAGR 5Y | -16.2% | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $95M | $139M | $140M | $111M | $134M | $125M | $27M | $477M | |
| Net Income TTM | $23M | $59M | $68M | $34M | $69M | $56M | $-7M | $422M | |
| Market Cap | $438M | $429M | $398M | $535M | $553M | $561M | $388M | $638M | |
| Enterprise Value | · | · | · | · | · | $443M | $402M | · | |
| P/E | 19.1 | 7.3 | 5.9 | 16.0 | 8.3 | 10.2 | -31.8 | 1.5 | |
| P/S | 4.6 | 3.1 | 2.8 | 4.8 | 4.1 | 4.5 | 14.5 | 1.3 | |
| P/B | 2.2 | 2.0 | 2.0 | 3.1 | 3.2 | 4.3 | 4.0 | 6.2 | |
| P / Tangible Book | 2.2 | 2.0 | 2.0 | 3.2 | 3.2 | 4.4 | · | · | |
| P / Cash Flow | 10.1 | 8.8 | 4.2 | 12.9 | 48.1 | 7.8 | -21.3 | 9.3 | |
| P / FCF | · | · | · | · | · | · | -21.3 | 9.3 | |
| EV / EBITDA | · | · | · | · | · | 5.2 | -224.2 | · | |
| EV / FCF | · | · | · | · | · | · | -22.1 | · | |
| EV / Revenue | · | · | · | · | · | 3.5 | 15.0 | · | |
| Dividend Yield | 9.8% | 9.9% | 8.1% | 6.2% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 5.2% | 13.6% | 17.0% | 6.2% | 12.1% | 9.8% | -3.1% | 65.6% | |
| Payout Ratio | 185.2% | 72.0% | 47.2% | 97.2% | · | · | · | · | |
| Annual Payout | $43M | $43M | $32M | $33M | $0 | $0 | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $6M | $4M | $3M | $81M | $7M | $81M | $10M | $22M | $25M | $116M | $9M | $6M | $8M | $11M | $72M | |
| Cost of Revenue | $18M | $3M | $3M | $1M | $26M | $157.7K | $14M | $2M | $12M | $3M | $15M | $896.5K | $974.4K | $1M | $881.4K | $4M | |
| R&D Expense | $4M | $4M | $5M | $7M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $6M | $6M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $6M | $7M | $5M | $6M | $8M | $7M | $6M | $4M | $4M | $6M | $20M | |
| Operating Expenses | $27M | $12M | $13M | $13M | $35M | $9M | $24M | $9M | $21M | $14M | $25M | $11M | $11M | $10M | $13M | $29M | |
| Operating Income | $14M | $-5M | $-9M | $-10M | $46M | $-2M | $57M | $542.1K | $1M | $11M | $92M | $-1M | $-5M | $-2M | $-2M | $43M | |
| Other Non-op | $946.9K | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $1M | $883.1K | $1M | $890.6K | $677.2K | $259.0K | |
| Pretax Income | $15M | $-4M | $-8M | $-8M | $47M | $-570.4K | $59M | $2M | $2M | $13M | $93M | $-426.1K | $-3M | $-1M | $-1M | $43M | |
| Income Tax | $2M | $-589.4K | $-3M | $-2M | $12M | $-162.2K | $13M | $528.6K | $565.2K | $3M | $21M | $-33.0K | $-572.2K | $-299.4K | $-315.7K | $10M | |
| Net Income | $12M | $-3M | $-5M | $-6M | $35M | $-408.2K | $46M | $1M | $2M | $10M | $72M | $-393.1K | $-3M | $-918.3K | $-811.8K | $33M | |
| EPS (Basic) | $0.17 | $-0.05 | $-0.07 | $-0.09 | $0.50 | $-0.01 | $0.64 | $0.02 | $0.03 | $0.14 | $1.01 | $-0.01 | $-0.04 | $-0.01 | $-0.02 | $0.45 | |
| EPS (Diluted) | $0.17 | $-0.05 | $-0.07 | $-0.09 | $0.49 | $-0.01 | $0.63 | $0.02 | $0.03 | $0.14 | $1.01 | $-0.01 | $-0.04 | $-0.01 | $-0.01 | $0.45 | |
| Shares (Basic) | 71,752,539 | 71,649,957 | · | 71,604,956 | 71,465,521 | 71,427,527 | · | 71,368,585 | 71,152,572 | 71,093,653 | · | 71,084,735 | 71,090,642 | 72,197,038 | · | 73,024,147 | |
| Shares (Diluted) | 71,883,798 | 71,649,957 | · | 71,604,956 | 71,748,888 | 71,427,527 | · | 71,766,503 | 71,753,231 | 71,562,996 | · | 71,084,735 | 71,090,642 | 72,197,038 | · | 73,259,272 | |
| EBITDA | $14M | $-5M | · | $-10M | $46M | $-2M | · | $542.1K | $1M | $11M | · | $-1M | $-5M | $-2M | · | $43M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $118M | $146M | $155M | $172M | $182M | $162M | $155M | $99M | $107M | $144M | · | $71M | $76M | $116M | · | $110M | |
| Receivables | $7M | $5M | $3M | $2M | $6M | $7M | $21M | $12M | $9M | $18M | · | $8M | $6M | $12M | · | $55M | |
| Inventory | $41M | $56M | $49M | $48M | $36M | $59M | $50M | $62M | $56M | $64M | · | $65M | $50M | $43M | · | $31M | |
| Prepaid Expense | $5M | $5M | $6M | $5M | $5M | $5M | $5M | $7M | $5M | $2M | · | $2M | $2M | $2M | · | $964.1K | |
| Current Assets | $170M | $212M | $213M | $228M | $229M | $234M | $231M | $181M | $176M | $228M | · | $146M | $134M | $173M | · | $197M | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | · | $1M | $2M | $2M | · | $2M | |
| PP&E (Gross) | $8M | $8M | $8M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | · | $7M | $7M | $7M | · | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | · | $5M | $5M | $5M | · | $5M | |
| Goodwill | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | $898.3K | · | $898.3K | $898.3K | $898.3K | · | $898.3K | |
| Other Non-current Assets | $140.1K | $203.4K | $192.9K | $202.0K | $212.7K | $226.5K | $240.7K | $253.6K | $2M | $2M | · | $2M | $2M | $2M | · | $261.8K | |
| Total Assets | $176M | $219M | $219M | $232M | $235M | $247M | $244M | $195M | $193M | $243M | · | $158M | $147M | $184M | · | $204M | |
| Accounts Payable | $909.8K | $6M | $824.5K | $5M | $1M | $1M | $1M | $1M | $1M | $3M | · | $564.3K | $1M | $1M | · | $2M | |
| Accrued Liabilities | $7M | $7M | $7M | $9M | $7M | $16M | $6M | $7M | $7M | $6M | · | $30M | $18M | $16M | · | $16M | |
| Current Liabilities | $8M | $65M | $18M | $25M | $23M | $28M | $25M | $22M | $21M | $75M | · | $31M | $19M | $18M | · | $27M | |
| Capital Leases | · | $100.0K | $200.0K | $300.0K | $500.0K | $700.0K | · | $1M | $1M | $800.0K | · | · | · | · | · | · | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $10M | $68M | $21M | $28M | $26M | $31M | $29M | $26M | $25M | $78M | · | $34M | $22M | $22M | · | $31M | |
| Common Stock | $7.2K | $7.2K | $7.2K | $7.2K | $7.2K | $7.1K | $7.1K | $7.1K | $7.1K | $7.1K | · | $7.1K | $7.1K | $7.2K | · | $7.3K | |
| Retained Earnings | $-78M | $-90M | $-43M | $-38M | $-31M | $-23M | $-23M | $-69M | $-70M | $-72M | · | $-111M | $-111M | $-72M | · | $-60M | |
| Stockholders' Equity | $165M | $152M | $199M | $203M | $209M | $216M | $216M | $169M | $168M | $165M | $197M | $124M | $124M | $162M | $170M | $173M | |
| Liabilities + Equity | $176M | $219M | $219M | $232M | $235M | $247M | $244M | $195M | $193M | $243M | · | $158M | $147M | $184M | · | $204M | |
| Shares Outstanding | 71,844,042 | 71,724,097 | 71,611,302 | 71,611,302 | 71,539,755 | 71,441,083 | 71,404,669 | 71,369,274 | 71,305,893 | 71,122,516 | · | 71,091,616 | 71,082,944 | 71,535,268 | · | 73,024,147 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $150.1K | $149.9K | $146.5K | $141.8K | $139.0K | $100.0K | $138.4K | $120.7K | $161.5K | $100.0K | $100.0K | $135.2K | $168.9K | $100.0K | $100.0K | $143.8K | |
| Stock-based Comp | $1M | $753.0K | $772.5K | $774.1K | $1M | $902.3K | $764.1K | $813.8K | $932.3K | $1M | $462.5K | $459.8K | $721.4K | $408.7K | $686.4K | $328.7K | |
| Deferred Tax | $2M | $-657.9K | $-3M | $2M | $7M | $-277.9K | $1M | $-492.8K | $-600.3K | $36.5K | $-3M | $-305.8K | $-857.9K | $-483.4K | $-2M | $-1M | |
| Other Non-cash | · | $-5M | · | · | · | $7M | · | · | · | $-18M | · | · | · | $25M | · | · | |
| Operating Cash Flow | $15M | $-9M | $-17M | $-10M | $63M | $7M | $56M | $-7M | $6M | $-6M | $79M | $-5M | $-4M | $24M | $-8M | $-5M | |
| Investing Cash Flow | $0 | $0 | $-40.5K | $-289.6K | $-1 | $-24.9K | $-17.8K | $-22.4K | $-2.2K | $0 | $0 | $0 | $-21.7K | $0 | $0 | $0 | |
| Stock Repurchased | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $4M | $8M | $3M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $-8M | · | · | |
| Dividends Paid | $43M | $159.4K | $87.8K | $162.0K | $43M | $0 | $0 | $-8.5K | · | · | $0 | $0 | · | · | $-3.9K | $0 | |
| Financing Cash Flow | $-43M | $-740.4K | $-87.8K | $-403.5K | $-43M | $-166.2K | $-161.8K | $-274.1K | $-43M | $-159.0K | $0 | $0 | $-36M | $-8M | $-3M | $0 |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 33.9% | -85.2% | · | -390.2% | 56.3% | -32.0% | · | 5.4% | 5.0% | 44.3% | · | -14.2% | -78.9% | -25.3% | · | 59.4% | |
| Net Margin | 30.4% | -55.3% | · | -243.0% | 43.7% | -5.8% | · | 13.4% | 8.4% | 40.4% | · | -4.3% | -48.9% | -11.0% | · | 45.8% | |
| Pretax Margin | 36.2% | -64.8% | · | -318.9% | 58.3% | -8.1% | · | 18.7% | 11.0% | 52.0% | · | -4.6% | -58.7% | -14.6% | · | 59.7% | |
| EBITDA Margin | 33.9% | -82.8% | · | -390.2% | 56.3% | -30.1% | · | 5.4% | 5.0% | 44.9% | · | -14.2% | -78.9% | -23.8% | · | 59.4% | |
| ROA | 6.1% | -1.5% | · | -3.0% | 16.6% | -0.17% | · | 0.76% | 1.1% | 4.8% | · | -0.22% | -1.9% | -0.50% | · | 19.4% | |
| ROE | 6.7% | -1.9% | · | -3.4% | 18.8% | -0.21% | · | 0.92% | 1.3% | 6.3% | · | -0.26% | -2.2% | -0.56% | · | 23.6% | |
| ROIC | 7.1% | -3.0% | · | -3.8% | 16.4% | -0.75% | · | 0.23% | 0.49% | 5.3% | · | -0.97% | -3.1% | -0.98% | · | 19.0% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 21.7 | 3.2 | · | 9.2 | 10.1 | 8.4 | · | 8.1 | 8.3 | 3.0 | · | 4.7 | 7.1 | 9.3 | · | 7.2 | |
| Quick Ratio | 15.9 | 2.3 | · | 7.0 | 8.3 | 6.1 | · | 5.0 | 5.4 | 2.2 | · | 2.6 | 4.3 | 6.9 | · | 6.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.0 | · | 0.0 | 0.4 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.0 | 0.0 | · | 0.4 | |
| Inventory Turnover | 0.5 | 0.1 | · | 0.0 | 0.6 | 0.0 | · | 0.0 | 0.2 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 6.0 | 1.1 | · | 0.4 | 10.5 | 0.6 | · | 1.0 | 2.9 | 1.7 | · | 0.3 | 0.5 | 0.9 | · | 2.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.30 | $2.11 | · | $2.84 | $2.93 | $3.03 | · | $2.37 | $2.35 | $2.32 | · | $1.75 | $1.75 | $2.27 | · | $2.37 | |
| Revenue / Share | $0.57 | $0.09 | · | $0.04 | $1.13 | $0.10 | · | $0.14 | $0.30 | $0.36 | · | $0.13 | $0.08 | $0.12 | · | $0.99 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $0.10 | · | · | · | $-0.09 | · | · | · | $0.34 | · | · | |
| Cash / Share | $1.64 | $2.03 | · | $2.40 | $2.55 | $2.27 | · | $1.39 | $1.50 | $2.02 | · | $1.00 | $1.07 | $1.62 | · | $1.50 | |
| Dividend Paid / Share | $0.60 | $0.60 | · | · | $0.60 | · | $0.00 | $0.60 | · | · | $0.00 | $0.00 | $0.45 | $0.45 | $0.00 | $0.00 | |
| EPS (TTM) | $-0.04 | $0.28 | · | $1.02 | $1.13 | $0.67 | · | $1.20 | $1.17 | $1.10 | · | $-0.07 | $0.39 | $0.46 | · | $1.44 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $54M | $94M | · | $172M | $180M | $120M | · | $174M | $173M | $157M | · | $35M | $98M | $109M | · | $215M | |
| Net Income TTM | $-3M | $20M | · | $74M | $82M | $49M | · | $86M | $84M | $79M | · | $-5M | $28M | $33M | · | $108M | |
| Market Cap | $262M | $384M | · | $655M | $466M | $391M | · | $482M | $541M | $609M | · | $373M | $359M | $411M | · | $752M | |
| P/E | -91.0 | 19.1 | · | 9.0 | 5.8 | 8.2 | · | 5.6 | 6.5 | 7.8 | · | -75.0 | 12.9 | 12.5 | · | 7.2 | |
| P/S | 4.9 | 4.1 | · | 3.8 | 2.6 | 3.3 | · | 2.8 | 3.1 | 3.9 | · | 10.7 | 3.7 | 3.8 | · | 3.5 | |
| P/B | 1.6 | 2.5 | · | 3.2 | 2.2 | 1.8 | · | 2.8 | 3.2 | 3.7 | · | 3.0 | 2.9 | 2.5 | · | 4.3 | |
| P / Tangible Book | 1.6 | 2.5 | · | 3.2 | 2.2 | 1.8 | · | 2.9 | 3.2 | 3.7 | · | 3.0 | 2.9 | 2.6 | · | 4.4 | |
| P / Cash Flow | · | -44.3 | · | · | · | 55.4 | · | · | · | -99.5 | · | · | · | 16.8 | · | · | |
| Dividend Yield | 16.7% | 11.3% | · | 6.6% | 9.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.1% | 5.2% | · | 11.2% | 17.3% | 12.2% | · | 17.8% | 15.4% | 12.8% | · | -1.3% | 7.7% | 8.0% | · | 14.0% | |
| Payout Ratio | · | -4.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Annual Payout | $44M | $43M | · | $43M | $43M | · | · | · | · | · | · | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $95M | $139M | $140M | $111M | $134M |
| Betriebsgewinnmarge % | 25.1% | 50.4% | 59.8% | 38.6% | 66.6% |
| Nettoergebnis | $23M | $59M | $68M | $34M | $69M |
| Verwässerte EPS | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 11.8 | 9.1 | 4.4 | 8.6 | 6.8 |
| Quick Ratio | 8.8 | 7.0 | 3.2 | 6.7 | 6.1 |
Keine Daten für diese Aufstellung
Noch nicht genügend Fundamentaldaten vorhanden, um diese Aufstellung zu erstellen.
Institutionelle Eigentümer (13F) 176 Einreicher · $148.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
176
Gehaltener Wert
$148.3M
Neue Positionen
19
Geschlossene Positionen
33
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 19 (-10 vs. Vorquartal) | 33 (-3 vs. Vorquartal) | 80 (+16 vs. Vorquartal) | 46 (-19 vs. Vorquartal) | +816K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $16.642.113 | 2.723.750 | 11,22% | Aktien |
| BlackRock, Inc. | $15.238.067 | 4.186.282 | 10,28% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $9.899.037 | 2.719.568 | 6,68% | Aktien |
| AltraVue Capital, LLC | $8.470.804 | 2.327.144 | 5,71% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.234.232 | 1.712.701 | 4,20% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $5.482.077 | 1.506.065 | 3,70% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $5.368.334 | 1.474.817 | 3,62% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.159.233 | 1.417.092 | 3,48% | Aktien |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | $4.877.174 | 1.339.883 | 3,29% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $4.535.410 | 1.245.992 | 3,06% | Aktien |
| STATE STREET CORP | $4.127.720 | 1.133.989 | 2,78% | Aktien |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $3.327.131 | 914.047 | 2,24% | Aktien |
| Qube Research & Technologies Ltd | $2.696.912 | 740.910 | 1,82% | Aktien |
| Foundry Partners, LLC | $2.453.851 | 447.783 | 1,65% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $2.150.370 | 590.761 | 1,45% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $2.109.740 | 579.599 | 1,42% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $2.063.381 | 566.863 | 1,39% | Aktien |
| Uniplan Investment Counsel, Inc. | $2.039.686 | 560.353 | 1,38% | Aktien |
| CITADEL ADVISORS LLC | $2.006.535 | 551.246 | 1,35% | Aktien |
| ROYCE & ASSOCIATES LP | $2.005.676 | 551.010 | 1,35% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2.000.897 | 549.697 | 1,35% | Aktien |
| Legato Capital Management LLC | $1.863.822 | 512.039 | 1,26% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.555.282 | 427.275 | 1,05% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.549.912 | 425.800 | 1,05% | Aktien |
| MORGAN STANLEY | $1.532.474 | 421.009 | 1,03% | Aktien |
| DENALI ADVISORS LLC | $1.508.547 | 414.436 | 1,02% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.430.545 | 393.007 | 0,96% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $1.302.083 | 357.715 | 0,88% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.273.345 | 349.820 | 0,86% | Aktien |
| NORTHERN TRUST CORP | $1.215.152 | 333.833 | 0,82% | Aktien |
| Cubist Systematic Strategies, LLC | $1.161.271 | 126.915 | 0,78% | Aktien |
| Brandywine Global Investment Management, LLC | $1.069.433 | 175.030 | 0,72% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.009.583 | 277.358 | 0,68% | Aktien |
| JANUS HENDERSON GROUP PLC | $1.003.237 | 187.521 | 0,68% | Aktien |
| Creative Planning | $1.002.922 | 275.528 | 0,68% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $995.620 | 273.522 | 0,67% | Aktien |
| Bank of New York Mellon Corp | $967.089 | 265.684 | 0,65% | Aktien |
| D. E. Shaw & Co., Inc. | $964.236 | 264.900 | 0,65% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $946.626 | 260.062 | 0,64% | Aktien |
| AMERIPRISE FINANCIAL INC | $703.860 | 193.368 | 0,47% | Aktien |
| UBS Group AG | $662.473 | 181.998 | 0,45% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $598.416 | 164.400 | 0,40% | Aktien |
| FIRST TRUST ADVISORS LP | $580.612 | 159.509 | 0,39% | Aktien |
| Man Group plc | $572.747 | 157.348 | 0,39% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $528.019 | 145.060 | 0,36% | Aktien |
| STRS OHIO | $488.488 | 134.200 | 0,33% | Aktien |
| Campbell & CO Investment Adviser LLC | $441.084 | 121.177 | 0,30% | Aktien |
| Invesco Ltd. | $411.651 | 113.091 | 0,28% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $382.579 | 71.510 | 0,26% | Aktien |
| PRUDENTIAL FINANCIAL INC | $379.252 | 104.190 | 0,26% | Aktien |
Aktivisten & 5%+-Eigentümer 13 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Esopus Creek Value Series Fund LP – Series A, Rainy Daze LLC, Esopus Creek Management LLC, Hutch Master Fund Ltd., Hutch Capital Management LLC, Andrew L. Sole, Paul Saunders, Jr. ×7 Einreichungen | 22. November 2021 | · | Erste Einreichung | · | SEC |
| MacAndrews & Forbes Incorporated, MacAndrews & Forbes Group LLC, MFV Holdings One LLC, ST Holdings One LLC ×3 Einreichungen | 17. September 2021 | · | Erste Einreichung | Kapitalstruktur | SEC |
| MacAndrews & Forbes Holdings Inc., MacAndrews & Forbes LLC ×10 Einreichungen | 12. November 2014 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 9. Januar 2004 | · | Erste Einreichung | · | SEC |
| Mafco Holdings Inc., MacAndrews & Forbes Holdings Inc., TransTech Pharma, Inc. | 15. Oktober 2003 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 25. August 2003 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 11. Juli 2003 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter | 6. Februar 2002 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 3. Oktober 2001 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 21. Juni 2001 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 4. Juni 2001 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 14. Mai 2001 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 6. April 2001 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 43 Insider · 10 Führungskräfte · 31 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Diem Nguyen | Chief Executive Officer | 13. März 2026 A | 138.767 | 0 | 0 | $0 |
| Phillip Louis Gomez III | Chief Executive Officer | 9. Dezember 2019 P | 475.782 | 0 | 0 | $0 |
| Daniel J Luckshire | Executive VP & CFO | 13. März 2026 A | 280.493 | 0 | 0 | $0 |
| Ayelet Dugary | Acting Chief Financial Officer | 5. März 2009 A | · | 0 | 0 | $0 |
| Thomas N Konatich | Chief Financial Officer | 1. April 2008 E | · | 0 | 0 | $0 |
| Larry R. Miller | General Counsel | 25. März 2026 M | 51.912 | 0 | 0 | $0 |
| Dennis E Hruby | EVP & Chief Scientific Officer | 13. März 2026 A | 198.537 | 0 | 0 | $0 |
| Jay Varma | EVP & Chief Medical Officer | 11. Juni 2024 M | 17.298 | 0 | 0 | $0 |
| Robin Elizabeth Abrams | General Counsel and CAO | 31. Juli 2021 M | 49.787 | 0 | 0 | $0 |
| William J Haynes II | Executive VP & General Counsel | 23. September 2015 M | 63.937 | 0 | 0 | $0 |
| Holly L. Phillips | Direktor | 9. Juni 2026 A | 73.754 | 0 | 0 | $0 |
| Gary J. Nabel | Direktor | 9. Juni 2026 A | 73.754 | 0 | 0 | $0 |
| Julian Nemirovsky | Direktor | 9. Juni 2026 A | 73.754 | 0 | 0 | $0 |
| Harold Eugene Ford Jr. | Direktor | 9. Juni 2026 A | 47.538 | 0 | 0 | $0 |
| Joseph W Marshall III | Direktor | 9. Juni 2026 A | 246.523 | 0 | 0 | $0 |
| John M Keane | Direktor | 9. Juni 2026 A | 16.881 | 0 | 0 | $0 |
| Jaymie A Durnan | Direktor | 9. Juni 2026 A | 88.754 | 0 | 0 | $0 |
| Evan A. Knisely | Direktor | 11. Juni 2024 A | 17.298 | 0 | 0 | $0 |
| Julie Kane | Direktor | 14. Juni 2022 A | 48.482 | 0 | 0 | $0 |
| Michael C. Plansky | Direktor | 14. Juni 2022 A | 75.982 | 0 | 0 | $0 |
| James Antal | Direktor | 14. Juni 2022 A | 116.857 | 0 | 0 | $0 |
| Thomas E Constance | Direktor | 15. Juni 2021 M | 327.806 | 0 | 0 | $0 |
| Eric A Rose MD | Direktor | 15. Juni 2021 M | 1.068.593 | 0 | 0 | $0 |
| Edward P. Taibi | Direktor | 6. August 2020 A | · | 0 | 0 | $0 |
| Paul G Savas | Direktor | 16. Juni 2020 A | 307.847 | 0 | 0 | $0 |
| Jeffrey B Kindler | Direktor | 21. Mai 2020 M | 127.339 | 0 | 0 | $0 |
| Michael J Bayer | Direktor | 4. Juni 2019 P | 132.244 | 0 | 0 | $0 |
| Andrew L Stern | Direktor | 17. Mai 2017 M | 77.865 | 0 | 0 | $0 |
| Frances F Townsend | Direktor | 15. Mai 2014 M | 32.000 | 0 | 0 | $0 |
| William C Bevins | Direktor | 15. Mai 2014 M | 80.000 | 0 | 0 | $0 |
| Michael Weiner MD | Direktor | 15. Mai 2014 M | 15.000 | 0 | 0 | $0 |
| Steven L Fasman | Direktor | 9. März 2011 A | 27.000 | 0 | 0 | $0 |
| Scott M Hammer | Direktor | 13. Mai 2010 A | · | 0 | 0 | $0 |
| Adnan M M Mjalli | Direktor | 30. September 2009 X | 20.983 | 0 | 0 | $0 |
| Mehmet C Oz MD | Direktor | 13. Mai 2009 A | 25.000 | 0 | 0 | $0 |
| Judy S Slotkin | Direktor | 14. Mai 2008 A | · | 0 | 0 | $0 |
| Donald G Drapkin | Direktor | 19. Dezember 2006 A | · | 0 | 0 | $0 |
| Donald G Drapkin | Direktor | 2. Juni 2005 A | · | 0 | 0 | $0 |
| TRANSTECH PHARMA INC | 10%-Eigentümer | 30. September 2009 X | 20.983 | 0 | 0 | $0 |
| Bruce Slovin | · | 17. Mai 2017 M | 194.167 | 0 | 0 | $0 |
| John Odden | · | 30. Dezember 2004 P | 55.240 | 0 | 0 | $0 |
| Bernard L Kasten | · | 11. Oktober 2004 P | 553.559 | 0 | 0 | $0 |
| Susan K Burgess | · | 9. Juni 2004 S | 365.783 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 27 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| MYLD · Cambria ETF Trust | 0,76% | 78.417 NS | 31. Juli 2026 | N-PORT |
| ABLS · Abacus FCF ETF Trust | 0,72% | 1.026 NS | 31. Juli 2026 | N-PORT |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,56% | 38.188 SH | 1. Oktober 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,18% | 34.217 NS | 31. Juli 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,07% | 2.710 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,05% | 93.444 SH | 19. August 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,04% | 299.366 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,03% | 146.648 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 5.094 SH | 1. Oktober 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 36.807 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 64.784 SH | 1. Oktober 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,01% | 303.452 NS | 31. Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 113.818 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,00% | 20.190 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.112.121 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 158.197 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 183.740 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 12.456 SH | 3. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 5.523 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 464.304 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.206.157 SH | 19. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 242.574 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.123 SH | 19. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 1.909 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,00% | 119.169 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 391.714 SH | 11. September 2026 | Täglich |
| SVAL · iShares Trust | · | 132.175 SH | 3. September 2026 | Täglich |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | · |
| FULC | $753M | -9.6 | 2752.0% | · | -26.6% | · |
| EYPT | $1.51B | -5.8 | -27.5% | -739.4% | -84.0% | · |
| ANTX | $31M | -1.0 | · | · | -57.7% | · |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| DERM | · | -16.4 | 10.2% | -18.5% | -44.7% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026